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Aggressive treatment of early fistula failure.
Background. Fistula failure has been classified as early and
late. Early failure refers to those cases in which the arterio-
venous (AV) fistula never develops to the point that it can be
used or fails within the first 3 months of usage. It has been
common practice to abandon these early failures; however,
aggressive evaluation and treatment of early fistula failures has
been shown to result in the salvage of a large percentage. The
two most common causes of the failure seen at this time are
juxta-anastomotic stenosis (JAS) and the presence of accessory
veins. Both of these can be easily diagnosed by physical exami-
nation. This study reports the results of early fistula failure
managed aggressively in an attempt at salvage.
Methods. These studies were conducted in six freestanding
outpatient interventional facilities in different regions of the
United States. Interventional nephrologists are employed at
all of these facilities except one that is operated by an interven-
tional radiologist. Each patient was first evaluated angiographi-
cally to identify the anatomy of their AV fistula and detect
abnormalities that might be present. Stenotic lesions were then
treated with angioplasty and accessory veins thought to be
significant were obliterated. All patients were then followed
to determine if the fistula was usable for dialysis.
Results. One hundred patients were identified that met the
definition of early failure. Venous stenosis was present in 78%
of these cases. In 43% of the cases, the lesion was in the JAS
location. In 15%, this was the only lesion present. In 24%, it
was associated with an accessory vein, in 6% with a proximal
stenosis, and in 4% with both. A proximal stenosis lesion was
present in the fistula in 36%. In 6%, it was associated with an
accessory vein, in 6% with a JAS, and in 4% with both. The
definition of arterial anastomosis stenosis was met in 38% of
the cases. This was always in association with JAS. In four
cases, a stenotic lesion was present in the artery above the
anastomosis. An accessory vein was present in 46% of the
cases. In 12% of the cases, this was the only lesion present. In
24% of the cases, this anomaly was associated with JAS, in
6% with proximal stenosis, and in 4% with both. Angioplasty
was performed to treat venous stenosis in 72% of the cases
with a 98% success rate. Angioplasty of the arterial anastomosis
was performed in 38 cases with a 100% success rate. Accessory
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vein obliteration was performed in 46% of the patients with
a 100% success rate. The overall complication rate in this series
was 4%, of these 3% were minor and 1% were major. It was
possible to initiate dialysis using the fistula in 92% of the cases.
Actuarial life-table analysis showed that 84% were functional
at 3 months, 72% at 6 months, and 68% at 12 months.
Conclusion. If correctable pathology is detected in patients
with early fistula failure, the incidence of correctable lesions
is relatively high and an aggressive therapeutic approach can
be expected to have a high yield.
The superiority of the native arteriovenous (AV) fis-
tula as a vascular access for chronic hemodialysis over
an AV graft is an accepted fact. In multiple studies, it
has been shown to have significantly improved patency
rates and lower complication and infection rates [1]. For
these reasons it has been recommended that maximum
efforts be exerted to increase the number of fistulae in
both incident and prevalent patients [2]. Coincident with
attempts to increase fistula prevalence, an increased
number of fistula failures occur [1]. Fistula failure can
be classified as early and late. Early failure refers to
those cases in which the AV fistula never develops to
the point that it can be used or fails within the first 3
months of usage. Late failure refers to those cases that
fail after 3 months of successful usage [3, 4]. Although
there is considerable overlap, the typical causes for fail-
ure in these two groups are somewhat different [3, 4].
The clinical manifestations of early fistula failure are
failure to develop adequately to permit repetitive cannu-
lation for dialysis and inadequate flow to support dialysis
and thrombosis. These are clinical diagnoses. However,
in general, they are related to anatomic problems [3–5].
Even in the case of patients diagnosed clinically as having
a thrombosed fistula, an anatomic lesion is generally
found to be the cause of the dysfunction. In most cases,
either no thrombus or very minimal thrombus is actually
present.
Although it has been common practice to abandon
these early failures, aggressive evaluation and treatment
of early fistula failures has been shown to result in the
salvage of a large percentage [5]. This study reports a
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prospective observational study in which early fistula




These studies were conducted in six freestanding out-
patient interventional facilities in different regions of
the United States (Baltimore, Maryland; Birmingham,
Alabama; Tyler, Texas; Detroit, Michigan; Cincinnati,
Ohio; and Riverside, California). Interventional nephrolo-
gists are employed in all of these facilities except one
that is operated by an interventional radiologist (P.A.).
The patient populations served by these laboratoriess
ranged from 475 to 2200. All patients referred to one of
these facilities for evaluation of early fistula failure over
a 15-month period (January 1, 2001 through January 31,
2002) were entered into the study. Each patient was first
evaluated angiographically to identify the anatomy of
their AV fistula and to detect abnormalities that might
be present. Stenotic lesions were then treated with angio-
plasty and accessory veins thought to be significant were
obliterated. All patients were then followed up to deter-
mine if the fistula was usable for dialysis. None of these
patients has been included in any previous report.
Definitions
Early fistula failure was defined as an AV fistula that
never developed to the point that it could be used or
failed within the first 3 months of usage. Venous stenosis
was defined as 50% or greater decrease in lumen diame-
ter based upon a comparison with the adjacent, normal
vein. These lesions were categorized into three categories
based upon location: (1) juxta-anastomotic, (2) proximal,
and (3) central. Juxta-anastomotic stenosis (JAS) was
defined as narrowing in that portion of the fistula imme-
diately adjacent to the arterial anastomosis (Fig. 1). Proxi-
mal venous stenosis was defined as a stenotic lesion any-
where in the vein from the juxta-anastomotic portion to
the central veins. Stenosis in the central veins (subclavian,
innominate, and superior vena cava) was classified as
central stenosis. Stenosis of the arterial anastomosis was
defined based upon the appearance of an inflated angio-
plasty balloon placed across the anastomosis. A 50%
defect in the balloon was required to be classified as a
stenotic anastomosis. A 4 mm balloon was used to evalu-
ate radial artery anastomoses and a 6 mm balloon was
used for brachial artery anastomoses. Arterial stenosis
was defined as a 50% or greater decrease in lumen diam-
eter based upon a comparison with the adjacent, normal
artery occurring in the main artery feeding the fistula.
For the purposes of this study, the fistula was defined as
that portion of the vein up to the elbow for forearm
fistulas and up to the shoulder for upper arm fistulas.
An accessory vein was defined as a branch coming off
of the main venous channel that comprised the fistula
(Fig. 2). These veins are normal variants of anatomy,
but they can cause problems with fistula development.
This is in contrast to a collateral vein, which is pathologic
and develops in response to a pressure changes that
result from a downstream stenosis. A decision to treat an
accessory vein was based upon a subjective assessment of
its significance judged by its size and flow. Augmentation
of downstream fistula pulse and thrill by manual occlu-
sion of the accessory vein was also helpful in making the
decision of significance. If there was an associated venous
stenosis in a downstream (proximal) location, the acces-
sory vein was evaluated for significance after the stenosis
was treated. A side branch that appears to be significant
in the presence of downstream stenosis can disappear or
appear insignificant after the stenotic lesion is resolved.
A functional fistula was defined as one that could be
cannulated and could support a dialysis blood flow of at
least 350 mL/min without recirculation. The duration of
functional patency or primary patency was defined as
that period of time that the fistula could be cannulated
successfully and support a dialysis blood flow of at least
350 mL/min without recirculation and without a repeat
procedure, the end point being the repeat procedure.
Description of procedures performed
Angiogram. An angiogram was performed as follows.
The AV fistula was first examined to determine the most
probable cause of the problem and its location. Based
upon this examination, a cannulation site was selected.
The AV fistula was then cannulated using a Micropunc-
ture needle (Cook, Bloomington, IN, USA). The micro-
puncture wire was inserted into the vein and was used
to introduce a 5 F dilator. Contrast was injected through
this dilator to visualize the fistula and draining veins. The
entire venous drainage up through the central circulation
was routinely evaluated in all cases. By occluding the
fistula downstream (proximal) from the tip of the dilator,
the distal vein, arterial anastomosis, and distal artery
were visualized (retrograde injection). It was never nec-
essary to use a blood pressure cuff or any other occlusion
device to attain a retrograde injection. The standard
angiogram procedure used in this study involved only
the cannulation of the vein (fistula). It was not necessary
to cannulate the artery routinely.
Angioplasty [percutaneous transluminal angioplasty
(PTA)]. A PTA (Fig. 1) was performed as follows. After
the AV fistula was cannulated and the initial angiogram
was performed, a guidewire was introduced. For lesions
downstream (antegrade) from the cannulation site, the
guidewire was passed through the draining veins up to
the level of the central veins. If the lesion was upstream
(retrograde) from the cannulation site, the guidewire
was generally passed across the arterial anastomosis. The
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Fig. 1. Radial-cephalic fistula with juxta-anastomotic stenosis. (A ) The
affected segment of vein. (B ) Postangioplasty treatment.
size of the angioplasty balloon was generally selected to
provide 20% to 30% overdilatation of the vein. Either
a 6  4 or an 8  4 angioplasty balloon was generally
used within the fistula and the draining veins up to the
level of the central veins. A 12 4 balloon was generally
used centrally. In most cases, if the balloon was to be used
across the arterial anastomosis, a 4 4 balloon was used
across a radial anastomosis and a 6  4 balloon across
a brachial anastomosis, depending upon the size of the
artery. Dilatation was affected using pressure generated
by hand with a 10 mL syringe for routine situations and
a 3 mL syringe for more resistant lesions. The result of
the dilatation was judged by comparison with the adja-
Fig. 2. Radial-cephalic fistula with large accessory vein. (A ) Initial
angiogram. A is cannulation site just above anastomosis. B is cephalic
vein comprising fistula, and C is accessory vein arising from lateral
aspect of fistula. (B ) Angiogram performed postcoil obliteration. Arrow
indicates location of coil.
cent normal vessel on a repeat angiogram. The success
of an angioplasty procedure was judged by anatomic
criteria (Fig. 1). The procedure was classified as success-
ful if there was less than a 30% residual lesion according
to National Kidney Foundation Dialysis Outcomes
Quality Initiative (NKF–K/DOQI) guidelines [6].
Accessory vein obliteration. Only those accessory veins
that were thought to be of significant size with significant
flow were treated. Although this determination was some-
what subjective, a size of at least one third of the diameter
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Fig. 3. Primary patency of patients with early fistula failure after ther-
apy. Primary patency is defined as that time period during which no
procedure or intervention is required to maintain patency or function.
of the fistula was generally required (Fig. 2). If the acces-
sory vein was associated with a downstream (antegrade)
stenosis, its significance was evaluated after treatment
of the stenosis. After the presence and location of the
accessory vein was identified by angiography, it was oblit-
erated either by ligation or by the insertion of a coil,
depending upon the operator’s preference. One of two
methods was used for vein ligation. If the vein was rela-
tively superficial and could be easily seen or felt, it was
ligated percutaneously. This involved placing a 3-0 nylon
suture (Ethilon) around the vein close to its junction
with the main trunk of the fistula [7]. No incision was
made. If it was thought that this percutaneous technique
was not possible, an incision was made and the vein was
ligated using a silk tie. The incision was then closed.
Insertion of a coil involved selective cannulation of the
accessory vein using a 5 F catheter followed by the inser-
tion of the coil through the catheter. The size of the
coil was selected based upon the size of the vein. The
selection of the method of vein obliteration was based
upon the operator’s choice. In all instances, the success
of obliteration was confirmed by an angiogram.
Data collection
The data were collected prospectively as part of a fully
electronic medical record. The data were validated by
auditing the electronic medical record, physician proce-
dure notes, and digital fluoroscopic images. Data col-
lected on these patients included patient age, primary
disease, date fistula was created, location of fistula, if
fistula become usable, date usable fistulas were first used,
duration of functional patency, and details of the proce-
dures performed. The Kaplan-Meier method was used
to calculate life-table analysis data.
RESULTS
To be included in this study, the patient had to meet
the definition of having an AV fistula that never devel-







Comorbid conditions 4.7 (average)
Diabetes % 48.7
Age of fistulas months 4.7 (average)







Table 2. Lesions identified
Type Number
Accessory vein 12
Accessory vein  JAS 24
Accessory vein  proximal venous stenosis 6
Accessory vein  JAS  proximal venous stenosis 4
JAS 15
Proximal venous stenosis 20
JAS  proximal venous stenosis 6
Diffusely small vein 3
Central stenosis 9
Arterial anastomosis stenosis 38
Arterial stenosis 4
JAS is juxta-anastomotic venous stenosis.
oped to the point that it could be used or failed within
the first 3 months of usage. A total of 100 patients met
this definition for inclusion in the study. Demographi-
cally (Table 1) the patients were characterized by being
70% male with a mean age of 61  14.3 years (range,
24 to 87 years). Ethnically, 67% of the cases were African
American. The average number of comorbid conditions
was 4.7; diabetes was present in 48.7%.
By type, 55% of the fistulas were radial-cephalic, 39%
were brachial-cephalic, and 6% were brachial-basilic
transpositions (Table 1). The fistulas were located in the
left arm in 76% of the cases and in the right in 24%.
The average age of the fistulas at the time of treatment
was 4.7 months. As shown in Table 2, a variety of lesions
were identified. Venous stenosis was present in 78% of
the cases. In 43% of the cases, the lesion was in the JAS
location. In 15%, this was the only lesion present. In
24%, it was associated with an accessory vein, in 6%
with a proximal stenosis, and in 4% with both. A proxi-
mal stenosis lesion was present in the fistula in 36%. In
6%, it was associated with an accessory vein, in 6% with
a JAS, and in 4% with both. A central venous stenotic
lesion was present in 9% of the cases, but never as an
isolated lesion. It was always seen in association with
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another lesion. In one of these cases, the central vein
was totally occluded. In 3% of the cases, the vein com-
prising the fistula was diffusely narrow throughout its
entire length. The definition of arterial anastomosis ste-
nosis was met in 38% of the cases. This was always in
association with JAS. In four cases, a stenotic lesion
was present in the artery above the anastomosis. An
accessory vein considered to be significant according to
size and flow was present in 46% of the cases (46 pa-
tients). In 12% of the cases, this was the only lesion
present. In 24% of the cases, this anomaly was associated
with JAS, in 6% with proximal stenosis, and in 4% with
both. In all cases in which an accessory vein was associ-
ated with JAS, the vein in question originated down-
stream (antegrade) from the stenosis. A single accessory
vein (of significance) was present in 30 of the 46 cases,
two in 14 cases and three in two cases. All early failure
cases that were referred for evaluation had some type of
anatomic abnormality. None had negative angiograms.
Angioplasty was performed to treat venous stenosis
in 72% of the cases with a 98% success rate. The degree
of venous stenosis pretreatment was 74%  15% (50%
to 100%). This was reduced to 13% 15% (0% to 60%).
Angioplasty was judged to be unsuccessful in two cases.
Angioplasty of the arterial anastomosis was performed
in 38 cases with a 100% success rate. Accessory vein
obliteration was performed in all cases in which it was
present and thought to be significant (46% of the pa-
tients) with a 100% success rate. In 34 cases, this was
done using an intravascular coil, in 12 it was done by
ligation. In eight instances, ligation was accomplished
by surgical incision, in the remaining four, it was by
percutaneous ligation.
The complication rate for this study was determined
according to the reporting standards of the Society of
Cardiovascular and Interventional Radiology [8]. Ac-
cording to this standard, all complications, including pul-
monary and cardiac events that occur within 30 days of
the procedure, are considered procedure related. Minor
complications are those that require either no therapy
or only nominal therapy without any consequence. Major
complications are defined as those that require an in-
crease in the level of care, or result in hospitalization,
permanent adverse sequelae, or death. The overall com-
plication rate in this series was 4%, of these 3% were
minor and 1% were major. All of these adverse events
were associated with angioplasty procedures. The single
major complication consisted of a vein rupture with an
expanding hematoma. It resulted in loss of the access.
The three minor complications were all hematomas that
required no treatment and had no sequelae.
It was possible to initiate dialysis in 92% of the cases.
The eight failures included all three of the cases with
diffusely narrowed veins, the one case with central vein
occlusion, the case with a ruptured vein, and three cases
in which the fistula thrombosed prior to being used for
dialysis. Actuarial life-table analysis showed that 84%
were functional at 3 months, 72% at 6 months, and 68%
at 12 months (Fig. 3).
DISCUSSION
A major hurdle to achieving the goal of increasing the
numbers of AV fistulas in both prevalent and incident
patients is the frequency of early fistula failures. Aggres-
sive efforts at placing fistulas can be expected to increase
this frequency. Although the definitions varied, studies
of 20 to 25 years ago observed early failure rates in the
range of 10% to 25% [9–14]. In more recent reports, the
incidence has been higher, in the range of 20% to 50%
[15–29].
When listed, the most common cause for fistula failure
in these series has been failure to mature adequately for
use. The two most common identifiable causes for failure
in these cases are JAS and the presence of accessory
veins [4, 5, 30]. Frequently, these two conditions occur
together [4]. Both problems can be easily diagnosed by
physical examination [31, 32]. It is important to note that
in an optimum patient, either of these problems might
be present and not prevent fistula development. In fact,
in optimum patients, the presence of an accessory vein
might be beneficial, providing additional vessel for can-
nulation. The fact that these problems interfere with
fistula development may be evidence that the patient
was not an optimum candidate for such an access. Never-
theless, success is possible with aggressive management.
An aggressive approach to the evaluation of early fis-
tula failure to detect correctable problems, with appro-
priate intervention, has been shown to result in a high
salvage rate in these cases [5]. In that study, 71 patients
with early fistula failure were evaluated. Eight had inade-
quate arterial inflow and were not evaluated further. The
remaining 63 underwent ligation of an accessory vein,
angioplasty of a stenotic lesion, or both. Venous stenosis
was present in 33.3% of the cases, in 27% it was in the
JAS location. Accessory veins were present in 78% of
the cases; they were multiple in 44%. As a result of the
salvage attempts, 82.5% of the fistulas matured ade-
quately to support dialysis for a period of 90 days. The
1-year primary patency was 74.7%. In the current study,
the incidence of JAS was higher at 45%, while that of
accessory veins was considerably lower at 46%. Never-
theless, the salvage rate in both studies was comparable;
82.5% were able to support dialysis for 90 days in the
previous report and 84% in the current series. The 1-year
survival in the previous study exceeded that of the cur-
rent series, 74.7% versus 68%. The reasons for this are
not clear. It is important to note that none of the patients
of the previous series were included in the current study.
The existence of accessory veins and the concept of
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their contribution to the failure of a newly created AV
fistula to develop have been questioned [33, 34]. It has
been postulated that these side branches all develop in
response to downstream (antegrade) stenosis. Further,
it is alleged that simply treating the stenosis will cause
the veins in question to disappear. The demonstration
of cases in which this does not occur, or cases in which
there is no causative stenosis, is dismissed as evidence
that the offending stenotic lesion was simply missed. This
argument can be easily dispelled by a study of normal
anatomy. The veins that are used in the creation of fistu-
las have branches normally, especially the cephalic vein
in the forearm. While the number and pattern of these
branches is variable, they nevertheless exist in normal
anatomy. When a fistula is created, they do not go away.
In some patients, the accessory vein does not distract
from the development of the major vein into a usable
fistula. In fact, the accessory vein may develop to the
point that it too is usable for dialysis access. However,
under less than optimal circumstances, the accessory vein
can prevent the development of the fistula. As has been
shown in this study and previous reports [5, 7, 26], obliter-
ation of these veins can result in fistula salvage. The issue
is sometimes confused by the well-recognized fact that,
if there is a downstream stenosis, there is a tendency for
collateral veins to develop and a tendency for normal
side branches to become more prominent. This process
may be resolved by treating the stenosis. Unfortunately,
however, resolution of the stenosis does not always result
to a disappearance of the side branch. In these cases, we
consider obliteration of the vein to be a useful procedure.
In the current study, care was used to ensure that a
downstream stenosis was not present in any instance in
which an accessory vein was diagnosed and treated. It
is of interest to compare the reported results obtained
when accessory veins have been addressed and when
they have not. The primary patency at 90 days of 84%
and 1 year of 68% in the current study where these veins
were addressed is obviously superior to that of a previous
report of 67% and 39% [34], respectively, in which they
were ignored. This later study [34] also reported an im-
mediate complication rate of 13% with a 3% delayed
major complication rate. Whether this inordinately high
rate of complications could have contributed to their
poor result is not clear.
The current study is unique in that all causes of dys-
function were evaluated and all were aggressively treated.
This approach resulted in an excellent long-term success
rate in fistulas that had previously been unusable. This
success was attained with very few complications.
One must raise the question as to whether the anoma-
lies that result in early fistula failure are avoidable. The
answer to this question is suggested by a review of reports
in which aggressive patient evaluation was conducted
prior to fistula placement [1, 18, 26, 28, 35–38]. These
studies used venous mapping to evaluate patients prior
to access placement. Mixed results have been reported.
There appears to be no question that the use of vein
mapping will increase the likelihood of a fistula being
created as opposed to the placement of a synthetic graft,
but it will not ensure against early failures. In one study
[26], the number of patients that were ultimately dialyzed
with a fistula doubled with the use of vein mapping, but
of those that were created only 54% matured adequately
to be usable for dialysis. Early fistula failure has been
reported to be more common in females, even with vein
mapping to guide surgical creation of the access [39].
Even with an aggressive approach to intervention for
early failure, this report found a significant discrepancy
between the success rate in females and males [39]. This
reported difference between males and females was not
apparent from our data. However, it must be noted in
this study some degree of selectivity may be at play
because only those patients referred for evaluation by
their nephrologist were involved. In the previous study
[39], all cases from a single center were included.
The ultimate success of a fistula is also dependent
upon its depth. Optimally, it should be no more than
1 cm below the surface. Fistulas that are too deep cannot
be palpated well and, because of the length of the dialysis
needle, cannot be easily cannulated on a repetitive basis.
Data obtained at the time of vein mapping can serve as
a guide in selecting a target vein of an optimum depth
for fistula creation. It can also indicate the need to trans-
pose a vein to a more superficial location when no other
acceptable alternative is evident.
The type of aggressive approach used in this report
raises two additional questions: (1) how should fistula
adequacy be determined and (2) how early should a
newly created fistula be evaluated to detect problems
with development? Basically, fistula adequacy requires
two things, fistula maturation and blood flow. While
these are somewhat separate issues, they are also closely
interrelated. Maturation refers to changes that occur in
the vein comprising the fistula that allow for it to be
repetitively cannulated. Blood flow must be adequate to
support dialysis. Flow can be measured with a reasonable
degree of accuracy. It only needs to be marginally greater
than the dialysis blood pump rate [40]. If the patient is
to dialyze at a pump speed of 400 mL/min, a fistula blood
flow of 600 to 700 mL/min should be adequate to avoid
recirculation. The issue of cannulation is somewhat
harder to judge. It involves subjective elements that can-
not be measured. Nevertheless, vessel size is important
and that can be measured.
Robbin et al [41] found that if fistula diameter was
0.4 cm or greater, the chance that it would be adequate
for dialysis was 89% versus 44% if it was less than 0.4 cm.
The chances that the fistula would be adequate for dial-
ysis were 84% if the flow was 500 mL/min or greater but
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only 43% if it was less than this level. Combining the
two variables increased the predictive value of the mea-
surements. A minimum fistula diameter of 0.4 cm and a
minimum flow volume of 500 mL/min resulted in a 95%
chance that the fistula would be adequate versus 33% if
neither of the minimum criteria were met. Of consider-
able interest was the fact that experienced dialysis nurses
had an 80% accuracy in predicting the ultimate utility
of a fistula for dialysis. In this study, the ability of an
experienced dialysis nurse to successfully cannulate the
fistula and the ability of the access to support a minimum
dialysis blood flow of 350 mL/min was used as the criteria
to judge maturation.
Evaluation by physical examination at 30 days to de-
tect problems with adequacy has been recommended on
an empiric basis [5]. This was based upon the observation
that an AV fistula that did not appear to be adequate
at that time was generally not adequate at a later date.
Actually, increased blood flow occurs very early. In one
prospective study [42], average arterial blood flow preop-
eratively was 30 18 mL/min. Within 24 hours of surgery
to create a fistula, the fistula blood flow was up to 472 
315 mL/min, and by 1 week it had increased to 861 565
mL/min. In another study in which patients were divided
into two groups based upon the internal diameter of their
feeding artery [43], it was found that blood flow increased
from a preoperative level of 46  6 mL/min up to 184 
13 mL/min at 1 day, 202  14 mL/min at 1 week, 274 
17 mL/min at 3 weeks, 488  95 mL/min at 8 weeks,
and 562  131 mL/min at 12 weeks in the group with
the best results. This group had a feeding artery with an
internal diameter greater than 1.5 mm and a 12-week
primary patency rate of 83%. Robbin et al [36] found
that there was no significant difference in fistula blood
flow in the second, third, or fourth month following cre-
ation and that vessel diameter changed very little.
CONCLUSION
These studies suggest that a fistula that is going to
mature adequately for dialysis does so relatively early
and that evaluation after 1 month should detect those
that need further study. The fact that maturation can be
judged with 80% accuracy by physical examination [41]
and that the major causes of failure to mature can be
diagnosed by physical examination [31, 32] suggest that
the protocol for accomplishing this task can be very sim-
ple. An experienced person should examine a newly
created fistula at 4 weeks. If it does not appear to be
developing adequately for eventual use as a dialysis ac-
cess, it should be studied angiographically. If correctable
pathology is detected, it should be treated by endovascu-
lar means. If endovascular therapy is not effective, refer-
ral to the vascular surgeon should be considered. The
incidence of correctable lesions is relatively high and an
aggressive therapeutic approach can be expected to have
a high yield.
Reprint requests to Gerald A. Beathard, M.D., Ph.D., 2800 Way-
maker Way, #68 Austin, TX 78746.
E-mail: Gerald@beathard.com
REFERENCES
1. Allon M, Robbin ML: Increasing arteriovenous fistulas in hemo-
dialysis patients: Problems and solutions. Kidney Int 62:1109–1124,
2002
2. NKF-K/DOQI Clinical Practice Guidelines For Vascular Ac-
cess: Guideline 29: Goals of Access Placement—Maximizing Pri-
mary AV Fistulae. Am J Kidney Dis 37(Suppl 1):S169, 2001
3. Beathard GA: Strategy for maximizing the use of arteriovenous
fistulae. Semin Dial 13:291–296, 2000
4. Beathard GA: Angioplasty for arteriovenous grafts and fistulae.
Semin Neph 22:202–210, 2002
5. Beathard GA, Settle SM, Shields MW: Salvage of the nonfunc-
tioning arteriovenous fistula. Am J Kidney Dis 33:910–916, 1999
6. NKF-K/DOQI Clinical Practice Guidelines For Vascular Ac-
cess: Update 2000. Guideline 19: Treatment of Stenosis Without
Thrombosis in Dialysis AV Grafts and Primary AV Fistulae. Am
J Kidney Dis 37(Suppl 1):S163–S164, 2001
7. Faiyaz R, Abreo K, Zaman F, et al: Salvage of poorly developed
arteriovenous fistulae with percutaneous ligation of accessory
veins. Am J Kidney Dis 39:824–827, 2002
8. Aruny JE, Lewis CA, Cardella JF, et al: Quality improvement
guidelines for percutaneous management of the thrombosed or
dysfunctional dialysis access. J Vas Interv Radiol 10:491–498, 1999
9. Kinnaert P, Vereerstraeten P, Toussaint C, Van Geertruyden
J: Nine years’ experience with internal arteriovenous fistulas for
haemodialysis: A study of some factors influencing the results. Br
J Surg 64:242–246, 1977
10. Bonalumi U, Civalleri D, Rovida S, et al: Nine years’ experience
with end-to-end arteriovenous fistula at the “anatomical snuffbox”
for maintenance haemodialysis. Br J Surg 69:486–488, 1982
11. Reilly DT, Wood RF, Bell PR: Prospective study of dialysis
fistulas: Problem patients and their treatment. Br J Surg 69:549–
553, 1982
12. Palder SB, Kirkman RL, Whittemore AD, et al: Vascular access
for hemodialysis. Patency rates and results of revision. Ann Surg
202:235–239, 1985
13. Winsett OE, Wolma FJ: Complications of vascular access for
hemodialysis. South Med J 78:513–517, 1985
14. Kherlakian GM, Roedersheimer LR, Arbaugh JJ, et al: Compar-
ison of autogenous fistula versus expanded polytetrafluoroethylene
graft fistula for angioaccess in hemodialysis. Am J Surg 152:238–
243, 1986
15. Rocco MV, Bleyer AJ, Burkart JM: Utilization of inpatient and
outpatient resources for the management of hemodialysis access
complications. Am J Kidney Dis 28:250–256, 1996
16. Wong V, Ward R, Taylor J, et al: Factors associated with early
failure of arteriovenous fistulae for haemodialysis access. Eur J
Vasc Endovasc Surg 12:207–213, 1996
17. Hodges TC, Fillinger MF, Zwolak RM, et al: Longitudinal com-
parison of dialysis access methods: risk factors for failure. J Vasc
Surg 26:1009–1019, 1997
18. Silva MB, Jr, Hobson RW, 2nd, Pappas PJ, et al: A strategy
for increasing use of autogenous hemodialysis access procedures:
Impact of preoperative noninvasive evaluation. J Vasc Surg 27:302–
307, 1998
19. Hakaim AG, Nalbandian M, Scott T: Superior maturation and
patency of primary brachiocephalic and transposed basilic vein
arteriovenous fistulae in patients with diabetes. J Vasc Surg 27:154–
157, 1998
20. Golledge J, Smith CJ, Emery J, et al: Outcome of primary radio-
cephalic fistula for haemodialysis. Br J Surg 86:211–216, 1999
21. Miller PE, Tolwani A, Luscy CP, et al: Predictors of adequacy
of arteriovenous fistulas in hemodialysis patients. Kidney Int
56:275–280, 1999
Beathard et al: Early fistula failure1494
22. Ascher E, Gade P, Hingorani A, et al: Changes in the practice
of angioaccess surgery: Impact of dialysis outcome and quality
initiative recommendations. J Vasc Surg 31:84–92, 2000
23. Revanur VK, Jardine AG, Hamilton DH, Jindal RM: Outcome
for arterio-venous fistula at the elbow for haemodialysis. Clin
Transplant 14:318–322, 2000
24. Wolowczyk L, Williams AJ, Donovan KL, Gibbons CP: The
snuffbox arteriovenous fistula for vascular access. Eur J Vasc Endo-
vasc Surg 19:70–76, 2000
25. Gibson KD, Caps MT, Kohler TR, et al: Assessment of a policy
to reduce placement of prosthetic hemodialysis access. Kidney Int
59:2335–2345, 2001
26. Allon M, Lockhart ME, Lilly RZ, et al: Effect of preoperative
sonographic mapping on vascular access outcomes in hemodialysis
patients. Kidney Int 60:2013–2020, 2001
27. Oliver MJ, McCann RL, Indridason OS, et al: Comparison of
transposed brachiobasilic fistulas to upper arm grafts and brachio-
cephalic fistulas. Kidney Int 60:1532–1539, 2001
28. Sedlacek M, Teodorescu V, Falk A, et al: Hemodialysis access
placement with preoperative noninvasive vascular mapping: Com-
parison between patients with and without diabetes. Am J Kidney
Dis 38:560–564, 2001
29. Dixon BS, Novak L, Fangman J: Hemodialysis vascular access
survival: Upper-arm native arteriovenous fistula. Am J Kidney Dis
39:92–101, 2002
30. Romero A, Polo JR, Morato EG, et al: Salvage of angioaccess
after late thrombosis of radiocephalic fistulas for hemodialysis. Int
Surg 71:122–124, 1986
31. Beathard GA: Physical examination of the dialysis vascular access.
Semin Dial 11:231–236, 1998
32. Beathard GA: Physical examination: The forgotten tool, in A
Multidisciplinary Approach for Hemodialysis Access, edited by
Gray R, Sands J, New York, Lippincott Williams & Wilkins, 2002,
pp 111–118
33. Turmel-Rodrigues L: Diagnosis and endovascular treatment for
autologous fistulae-related stenoses, in A Multidisciplinary Ap-
proach for Hemodialysis Access, edited by Gray R, Sands J, New
York, Lippincott Williams & Wilkins, 2002, pp 170–183
34. Turmel-Rodrigues L, Mouton A, Birmele B, et al: Salvage of
immature fistulas for haemodialysis by interventional radiology.
Nephrol Dial Transplant 16:2365–2371, 2001
35. Rutherford RB: The value of noninvasive testing before and
after hemodialysis access in the prevention and management of
complications. Semin Vasc Surg 10:157–161, 1997
36. Robbin ML, Gallichio MH, Deierhoi MH, et al: US vascular
mapping before hemodialysis access placement. Radiology 217:83–
88, 2000
37. Mendes RR, Farber MA, Marston WA, et al: Prediction of wrist
arteriovenous fistula maturation with preoperative vein mapping
with ultrasonography. J Vasc Surg 36:460–463, 2002
38. Dalman RL, Harris JE, Victor BJ, Coogan SM: Transition to
all-autogenous hemodialysis access: The role of preoperative vein
mapping. Ann Vasc Surg 16:624–630, 2002
39. Miller CD, Robbin ML, Allon M: Gender differences in out-
comes of arteriovenous fistulas in hemodialysis patients. Kidney
Int 63:346–352, 2003
40. Sherman RA, Besarab A, Schwab SJ, Beathard GA: Recognition
of failing vascular access. Semin Dial 10:1–4, 1997
41. Robbin ML, Chamberlain NE, Lockhart ME, et al: Hemodialysis
arteriovenous fistula maturity: US evaluation. Radiology 225:59–
64, 2002
42. Yerdel MA, Kesenci M, Yazicioglu KM, et al: Effect of haemody-
namic variables on surgically created arteriovenous fistula flow.
Nephrol Dial Transplant 12:1684–1688, 1997
43. Malovrh M: Non-invasive evaluation of vessels by duplex sonogra-
phy prior to construction of arteriovenous fistulas for haemodial-
ysis. Nephrol Dial Transplant 13:125–129, 1998
